Biotech is one area where the US can afford to let China flourish
AI Summary
The US biotech industry is increasingly looking to China for innovative treatments and technologies, recognizing that China's rapid advancements in this sector could offer significant benefits. This strategic pivot underscores a pragmatic approach, acknowledging China's current lead in biotech development while leveraging its innovations for global markets. It highlights a broader trend of international collaboration in science and underscores the importance of global partnerships in driving medical progress.
Original Source
Read the full article at Ft →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.